Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) FCF Margin (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 16 years of FCF Margin data on record, last reported at 8.92% in Q2 2025.

  • For Q2 2025, FCF Margin rose 2013.0% year-over-year to 8.92%; the TTM value through May 2025 reached 10.57%, up 357.0%, while the annual FY2025 figure was 10.57%, 357.0% up from the prior year.
  • FCF Margin reached 8.92% in Q2 2025 per LFCR's latest filing, up from 12.57% in the prior quarter.
  • Across five years, FCF Margin topped out at 16.38% in Q2 2023 and bottomed at 70.94% in Q1 2023.
  • Average FCF Margin over 5 years is 17.14%, with a median of 16.08% recorded in 2021.
  • Peak YoY movement for FCF Margin: crashed -8394bps in 2021, then surged 7784bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 4.39% in 2021, then tumbled by -747bps to 28.36% in 2022, then skyrocketed by 62bps to 10.9% in 2023, then tumbled by -137bps to 25.85% in 2024, then soared by 134bps to 8.92% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 8.92% in Q2 2025, 12.57% in Q1 2025, and 25.85% in Q4 2024.